Funding Rounds
Curve Therapeutics

Curve Therapeutics Series A (2024, $51M)

Curve Therapeutics

Intracellular screening platform.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $51.36M

Investors